EPISODE · Oct 6, 2023 · 47 MIN
What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma
from Oncology Today with Dr Neil Love
Professor Philippe Moreau from the University Hospital of Nantes in France discusses anti-CD38 antibody-based treatment approaches for newly diagnosed and relapsed/refractory multiple myeloma moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here
Embed this episode
Ready to play
What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.